Consensus recommendations have been established for pediatric mycosis fungoides, including additional clinical severity and outcome measures.

Those who receive the COVID-19 vaccine during pregnancy are less likely to be hospitalized for COVID-19; however, vaccine uptake in this population is suboptimal.

Several minimally invasive injectable modalities are safe and effective for the management of hair loss in adults with androgenetic alopecia.

The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.

Extreme temperature-related deaths are projected to increase considerably by the mid-21st century in the contiguous United States.

The United States government is offering another round of free COVID-19 tests, which will be available by the end of September.

Fructose, carbonated soft drinks, and free sugar consumption may be linked to asthma, allergic rhinitis, and food allergies in children.

Topline results were announced from a trial evaluating dapirolizumab pegol in patients with moderate to severe systemic lupus erythematosus.

Zasocitinib at doses of 5 mg or greater vs placebo resulted in greater skin clearance among patients with moderate to severe plaque psoriasis.

High levels of well-being may protect against the risks for cardiovascular diseases, according to study findings.

The FDA has accepted for filing the NDA for delgocitinib cream as a treatment for moderate to severe chronic hand eczema in adults.

Policy interventions to mitigate heat-related illness are needed based on the relationship between high HVI and severe stroke.